Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.

The Medtronic HeartWare Ventricular Assist Devices (HVAD) has a Class I FDA recall.
Feature | Ventricular Assist Devices (VAD) | June 04, 2018

June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its...

Gencaro Does Not Reduce Atrial Fibrillation Risk in Heart Failure Patients
News | Heart Failure | May 30, 2018

May 30, 2018 — Data from the GENETIC-AF...

Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018

May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...

Cardiac Contractility Modulation Safe and Effective as Heart Failure Treatment

Image courtesy of Impulse Dynamics

News | Heart Failure | May 18, 2018

May 18, 2018 — In a new study, cardiac...

V-Wave Closes $70M Financing to Support Pivotal Study of Heart Failure Therapy
News | Heart Failure | May 16, 2018

May 16, 2018 — Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary,...

News | Heart Failure | May 14, 2018

May 14, 2018 — Ancora Heart Inc. announced the expansion of the company’s U.S....

Protein Clumping May Contribute to Heart Failure Development

A PET scan detects clumping proteins in rat hearts (top). The enlarged heart (right) is one with heart failure. Other PET scans showing blood flow in the rat hearts (bottom) show that the protein clumps aren't due to circulation problems. Image courtesy of Circulation Research, May 11, 2018.

News | Heart Failure | May 11, 2018

May 11, 2018 — A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to...

Minnesota Living With Heart Failure Questionnaire Qualified for FDA Medical Device Development Tools Program

The CORolla device from Israel-based CorAssist is one example of new devices being manufactured and tested to treat heart failure. The efficacy of this and other new devices under development can now be assessed with the Minnesota Living With Heart Failure Questionnaire. 

Technology | Heart Failure | May 07, 2018

May 7, 2018 — The U.S. Food and Drug Administration (FDA) has qualified the Minnesota Living with...

News | Hemodynamic Support Devices | April 12, 2018

April 12, 2018 – French medical technology company CorWave announced it has been awarded almost $3.5 million in...

Pfizer Announces Positive Topline Results from Phase 3 ATTR-ACT Study
News | Pharmaceuticals | April 06, 2018

April 6, 2018 — Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met...

Nation's First Heart Failure and Arrhythmia Center Opening in Ohio

Image courtesy of The Ohio State University

News | Heart Failure | April 04, 2018

April 4, 2018 — The Ohio State University Wexner Medical Center will establish the nation’s first center dedicated...

Abbott Initiates GUIDE-HF Trial for Improved Outcomes With CardioMEMS Monitor
News | Heart Failure | March 29, 2018

March 29, 2018 — Abbott announced the company has initiated the landmark GUIDE-HF...

Videos | Heart Failure | March 23, 2018

David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit,...

American College of Cardiology Expands Patient Navigator Program
News | Cath Lab | March 21, 2018

March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help...

Overlay Init